Need for a paradigm shift: the importance of risk factor reduction therapy in treating patients with cardiovascular disease
- 26 November 1998
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 82 (10) , 10-13
- https://doi.org/10.1016/s0002-9149(98)00716-4
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The Effect of Aggressive Lowering of Low-Density Lipoprotein Cholesterol Levels and Low-Dose Anticoagulation on Obstructive Changes in Saphenous-Vein Coronary-Artery Bypass GraftsNew England Journal of Medicine, 1997
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical eventsJournal of the American College of Cardiology, 1995
- A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of AtherosclerosisCirculation, 1995
- Coronary Plaque DisruptionCirculation, 1995
- Molecular Bases of the Acute Coronary SyndromesCirculation, 1995
- Cholesterol Reduction in Cardiovascular Disease — Clinical Benefits and Possible MechanismsNew England Journal of Medicine, 1995
- Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology.Circulation, 1994
- Triggers, acute risk factors and vulnerable plaques: The lexicon of a new frontierJournal of the American College of Cardiology, 1994